GLPwatch
Papers (10389)
Page 147 of 174, ranked by citation count.
- The Sit Less, Interact and Move More (SLIMM-2) Trial: Protocol for a randomized control trial of a sedentary behavior intervention, resistance training and semaglutide on sedentary behavior in persons with chronic kidney disease.
- Healthy Weight Loss Maintenance with Exercise, Liraglutide, or Both Combined.
- Efficacy and Safety of Dulaglutide Biosimilar LY05008 Versus the Reference Product Dulaglutide (Trulicity) in Chinese Adults With Type 2 Diabetes Mellitus: A Randomized, Open-Label, Active Comparator Study.
- Dulaglutide slows kidney disease in type 2 diabetes.
- Challenges in Modelling the Cost Effectiveness of Pharmacotherapies for Obesity.
- Real-world clinical responses in patients with type 2 diabetes mellitus adding exenatide BID (EBID) or mealtime insulin to basal insulin: a retrospective study using electronic medical record data.
- The Risk of Vestibular Disorders with Semaglutide and Tirzepatide: Findings from a Large Real-World Cohort.
- [Basal insulin degludec - liraglutide fixed ratio combination (Xultophy®)].
- Changes to insulin requirements over time with semaglutide in adults with type 1 diabetes on insulin pump therapy: A post-hoc analysis of a double-blinded, randomised, crossover trial.
- Efficacy of Semaglutide Injection in the Treatment of Type 2 Diabetes Mellitus and its Impact on C-Peptide Levels.
- Therapy Combining Glucagon-Like Peptide-1 Receptor Agonist with Sodium-Glucose Cotransporter 2 Inhibitor Suppresses Atherosclerosis in Diabetic ApoE-Deficient Mice.
- Slimming cardiac adipose tissue with liraglutide: pericardial is not epicardial fat (the LIRAFLAME substudy).
- Healthy Weight Loss Maintenance with Exercise, Liraglutide, or Both Combined.
- Tirzepatide versus SGLT2 inhibitors for MASLD: a multi-institutional propensity score-matched cohort study.
- Efficacy and safety of dapagliflozin and liraglutide in patients with type 2 diabetes mellitus and newly diagnosed as overweight/obese.
- RGB Trichromatic Whiteness Assessment of Bio Analytical Chromatographic Tool Using Fluorescence for Quantitation of Semaglutide: Application to Pharmaceutical Preparations and Spiked Plasma.
- The global clinical trial landscape for non-alcoholic fatty liver disease (NAFLD): current status and future prospects.
- Inequity in adherence to empagliflozin and dulaglutide for type 2 diabetes in Aotearoa New Zealand.
- Decreased complexity of glucose dynamics in diabetes in rhesus monkeys.
- The effect of liraglutide on insulin allergy in a patient with glucocorticoid-induced diabetes and multiple sclerosis.
- Weight regain after bariatric surgery: A framework for management.
- "Why you should (not) use semaglutide?": A critical discourse analysis on health professionals' videos of semaglutide for weight loss on Douyin.
- [Changes in weight, body composition, metabolic parameters and vitamin D in subjects with grade 3 and 4 obesity treated with liraglutide 3 mg].
- SOUL searching in GLP-1 therapy: Oral semaglutide confirms cardioprotection in type 2 diabetes.
- [Pharmacotherapy of obesity in Germany].
- Various GLP-1 Receptor Agonist Preference Use with a Special Focus on Oral and Subcutaneous Forms in Poland.
- Effects of semaglutide in patients with chronic ankle instability: evidence from a prospective cohort.
- Response To "Superior Cerebrovascular Outcomes with Tirzepatide Versus Semaglutide: A Call for Cautious Interpretation of Observational Data".
- GLP-1 Receptor Agonist Medications for Obesity and Type 2 Diabetes Treatment: A Rapid Review of Changes in Eating Behaviors and Eating Disorder Risk.
- Semaglutide Reduces Cardiomyocyte Damage Caused by High-Fat Through HSDL2.
- Exploring the nephroprotective effects of combined finerenone and exenatide therapy in diabetic nephropathy.
- Efficacy and safety of iGlarLixi versus IDegAsp in people with type 2 diabetes inadequately controlled with basal insulin: A systematic literature review and network meta-analysis of non-Asian studies.
- Tirzepatide and change in uric acid and its association with weight reduction: post hoc analyses of the SURMOUNT-1 randomised placebo-controlled trial.
- First report on a case series of Patulous Eustachian tube following GLP-1 receptor agonist-induced weight loss.
- GLP-1RA Dispensing in Youth With Type 2 Diabetes: 2020 to 2023.
- Operationalising disease modification in obesity trials: A blueprint based on the SYNCHRONIZE-1 survodutide study.
- Comparison of IBD-related outcomes in patients with obesity treated with GLP-1 receptor agonists versus bariatric surgery.
- Suicidal Thoughts and Self-injurious Behavior Associated With Glucagon- Like Peptide-1 Receptor Agonists - A Review.
- Bezlotoxumab.
- Microbial expression of Exendin-4 analog and its efficacy in mice model.
- GLP-1 agonist-associated presentations to unscheduled care: An opportunistic pilot study.
- Diabetic kidney disease: The fourth pharmacological pillar may be semaglutide.
- A review regarding the article 'Semaglutide and heart failure: Updated meta-analysis'.
- [Treatment of non-alcoholic fatty liver disease].
- Impact of chemical structure, lipidation and formulation on luminal stability and intestinal absorption of GLP-1 analogues.
- GLP-1RA Liraglutide Attenuates Sepsis by Modulating Gut Microbiota and Associated Metabolites.
- Orforglipron, an Oral GLP-1 Receptor Agonist, in Early Type 2 Diabetes.
- [Efficacy of treatment with glucagon-like peptide receptor agonists-1 in Asian patients with type 2 diabetes mellitus].
- Real-World Effectiveness and Safety of Lixisenatide as Add-On to Oral Antidiabetic Drugs as Part of Routine Clinical Practice in Bulgaria: LIXODAR Study.
- Effectiveness of semaglutide on survival outcomes in patients with type 2 diabetes and chronic kidney disease.
- GLP-1 receptor agonists in stroke prevention: a narrative review on emerging therapeutic frontiers.
- Impact of GLP-1 and dual agonists on the incidence of new cases of physician-reported sleep apnea: a real-world study.
- Pharmacokinetic similarity study comparing the biosimilar candidate, LY05008, with its reference product dulaglutide in healthy Chinese male subjects.
- Neuroprotective Effects of Liraglutide and/or Rivastigmine Combination on the Rat Hippocampus.
- Liraglutide modulates adhesion molecules and enhances cell properties in three-dimensional cultures of olfactory ensheathing cells.
- Choosing injectable therapy: The metabolic fulcrum.
- Transformative weight loss with Dulaglutide: A case report of success in a challenging patient profile of an ex-sumo wrestler.
- Translating Guidelines into Practice: A Prospective Real-World Study of a Romanian Cohort Treated with GLP-1 RAs.
- Obesity treatment as a bridge to solid organ transplantation: A comparison of bariatric surgery to medical therapy.
- Tirzepatide on physical function in adults with overweight or obesity: A systematic review and meta-analysis.